Please use this identifier to cite or link to this item:
|Title:||Biomarkers of chronic traumatic encephalopathy: A state-of-the art review||Authors:||Gerges, Jennifer Abi
|Affiliations:||Faculty of Medicine||Keywords:||Biomarker
Chronic Traumatic Encephalopathy
Traumatic encephalopathy syndrome
|Issue Date:||2023-06||Publisher:||Elsevier||Part of:||Biomarkers in Neuropsychiatry||Volume:||8||Abstract:||
Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative condition that occurs several years following repetitive mild concussive or sub concussive brain injuries. To date, it is a post-mortem diagnosis. Traumatic encephalopathy syndrome (TES) is a framework that was developed as a clinical predictor of CTE in living individuals. Development of biomarkers of CTE, detectable through imaging or bodily fluids will aid improve the diagnostic accuracy of CTE in life, and help develop prevention and therapeutic strategies. This article reviews biomarkers investigated to date, and discusses challenges and future avenues in this burgeoning field.
|URI:||https://scholarhub.balamand.edu.lb/handle/uob/6854||DOI:||10.1016/j.bionps.2023.100066||Ezproxy URL:||Link to full text||Type:||Journal Article|
|Appears in Collections:||Faculty of Medicine|
Show full item record
checked on Dec 1, 2023
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.